{"id":"W4416265857","doi":"10.1016/j.ejca.2025.116106","title":"Corrigendum to “Talazoparib plus enzalutamide in metastatic castration-resistant prostate cancer: Safety analyses from the randomized, placebo-controlled, phase III TALAPRO-2 study” [Eur J Cancer 213 (December) (2024) 115078]","year":2025,"lang":"en","type":"article","venue":"European Journal of Cancer","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Enzalutamide; Incidence (geometry); Prostate cancer; Cancer; Population; Regret","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002644357,0.001736571,0.003351564,0.001796862,0.001696321,0.002726766,0.003167996,0.008163948,0.1065204],"category_scores_gemma":[0.0197575,0.001047246,0.002980037,0.0010939,0.00112037,0.001083528,0.001316318,0.006750509,0.04981904],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.003374989,"about_ca_system_score_gemma":0.003873341,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.01816026,"about_ca_topic_score_gemma":0.03092354,"domain_scores_codex":[0.9975551,0.0003722345,0.0002963829,0.0004741032,0.0009425076,0.0003597356],"domain_scores_gemma":[0.9901437,0.002437389,0.0007106019,0.0004345971,0.005157558,0.001116247],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00008542006,0.00001285304,0.00004674438,0.00007657546,0.0000231563,0.0001422751,0.000005750662,0.00002324396,0.00005549195,0.0001006538,0.9954509,0.003976941],"study_design_scores_gemma":[0.0006286664,0.0002095665,0.003478182,0.0002776941,0.0001810709,0.0005844228,0.00003848207,0.0003098011,0.0005651989,0.0007899299,0.9928591,0.00007791835],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"editorial","genre_gemma":"other","genre_scores_codex":[0.0003024152,0.006133237,0.0003507926,0.155472,0.8246585,0.0001427461,0.00208236,0.0004953549,0.01036261],"genre_scores_gemma":[0.007222103,0.00955216,0.0009059822,0.212276,0.5525458,0.0002217947,0.003094774,0.0003808911,0.2138005],"genre_candidate":"other","genre_consensus":null,"teacher_disagreement_score":0.1065204,"threshold_uncertainty_score":0.3563463,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05618062700535024,"score_gpt":0.4033525715823855,"score_spread":0.3471719445770352,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}